Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.05T
Market cap1.05T
Price-Earnings ratio
40.41
Price-Earnings ratio40.41
Dividend yield
0.58%
Dividend yield0.58%
Average volume
3.22M
Average volume3.22M
High today
$1,113.98
High today$1,113.98
Low today
$1,109.74
Low today$1,109.74
Open price
$1,115.21
Open price$1,115.21
Volume
7.34K
Volume7.34K
52 Week high
$1,182.73
52 Week high$1,182.73
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.05T, Eli Lilly(LLY) trades at $1,113.00. The stock has a price-to-earnings ratio of 40.41 and currently yields dividends of 0.58%.

On 2026-06-18, Eli Lilly(LLY) stock moved within a range of $1,109.74 to $1,113.98. With shares now at $1,113.00, the stock is trading +0.3% above its intraday low and -0.1% below the session's peak.

Trading activity shows a volume of 7.34K, compared to an average daily volume of 3.22M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.

LLY News

The Motley Fool 2h
Vanguard vs VanEck: Which Healthcare ETF Is the Better Buy?

Vanguard Health Care ETF (VHT 1.13%) provides broad-spectrum medical sector exposure at a low cost, while VanEck Pharmaceutical ETF (PPH 0.81%) offers concentra...

Vanguard vs VanEck: Which Healthcare ETF Is the Better Buy?
TipRanks 12h
Cathie Wood’s ARK Investment buys 41K shares of Eli Lilly today

20:31 EDT Cathie Wood’s ARK Investment buys 41K shares of Eli Lilly (LLY) today Published first on TheFly – the ultimate source for real-time, market-moving br...

TipRanks 20h
Eli Lilly Halts Mid‑Stage Rheumatoid Arthritis Trial: What It Means for LLY Investors

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
9.4%
Sell
6.3%

More LLY News

TipRanks 20h
Lilly’s TOGETHER-PsO Trial: A New Push To Link Psoriasis And Obesity Treatment

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

TipRanks 2d
M&A News: Eli Lilly Expands Into Painkiller Market with Latest Acquisition

Eli Lilly (LLY) is expanding into the market for non-addictive painkillers with its latest acquisition. Unlock powerful investing tools and data-driven insight...

Nasdaq 2d
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?

Key Points Eli Lilly currently leads the weight loss market. Novo Nordisk's newer launches could help it make up some ground. Both could capitalize on the gr...

Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
Barron's 2d
Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.

Biotech and Pharma Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work. In this article LLY Eli Lilly acquired Austin-based 4E T...

Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
TipRanks 2d
Eli Lilly Advances New Early‑Stage Drug With Fresh Clinical Trial Update

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

TipRanks 2d
Eli Lilly acquires 4E Therapeutics, terms not disclosed

4E Therapeutics, an Austin-based neuroscience company developing treatments for chronic pain, announced that it has been acquired by Eli Lilly (LLY). 4E says it...

TipRanks 2d
Novo Nordisk Seeks China Approval for Wegovy Pill, Intensifying Rivalry with Lilly

Novo Nordisk (NVO) is stepping up its competition with rival Eli Lilly (LLY) in China’s oral weight loss drug market. According to a Reuters report, CEO Mike Do...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.